Redcare Pharmacy NV

XTRA:RDC Stock Report

Market Cap: €974.2m

Redcare Pharmacy Past Earnings Performance

Past criteria checks 0/6

Redcare Pharmacy has been growing earnings at an average annual rate of 10.3%, while the Consumer Retailing industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 25% per year.

Key information

10.26%

Earnings growth rate

12.44%

EPS growth rate

Consumer Retailing Industry Growth10.52%
Revenue growth rate24.96%
Return on equity-8.22%
Net Margin-1.28%
Next Earnings Update06 May 2026

Recent past performance updates

Recent updates

Take Care Before Jumping Onto Redcare Pharmacy NV (ETR:RDC) Even Though It's 26% Cheaper

Nov 13
Take Care Before Jumping Onto Redcare Pharmacy NV (ETR:RDC) Even Though It's 26% Cheaper

Take Care Before Jumping Onto Redcare Pharmacy NV (ETR:RDC) Even Though It's 26% Cheaper

Sep 04
Take Care Before Jumping Onto Redcare Pharmacy NV (ETR:RDC) Even Though It's 26% Cheaper

Analyst Estimates: Here's What Brokers Think Of Redcare Pharmacy NV (ETR:RDC) After Its Second-Quarter Report

Aug 01
Analyst Estimates: Here's What Brokers Think Of Redcare Pharmacy NV (ETR:RDC) After Its Second-Quarter Report

Here's Why Redcare Pharmacy (ETR:RDC) Can Afford Some Debt

Jul 13
Here's Why Redcare Pharmacy (ETR:RDC) Can Afford Some Debt

Redcare Pharmacy NV (ETR:RDC) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Mar 14
Redcare Pharmacy NV (ETR:RDC) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?

Feb 27
Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?
User avatar

eRx Surge And International Expansion Poised To Elevate Revenue And Profit Margins

Rapid expansion in new markets and tech-driven efficiencies suggest future revenue growth and improved profit margins.

Here's Why Redcare Pharmacy (ETR:RDC) Can Afford Some Debt

Nov 11
Here's Why Redcare Pharmacy (ETR:RDC) Can Afford Some Debt

Is There Now An Opportunity In Redcare Pharmacy NV (ETR:RDC)?

Apr 21
Is There Now An Opportunity In Redcare Pharmacy NV (ETR:RDC)?

Are Investors Undervaluing Redcare Pharmacy NV (ETR:RDC) By 26%?

Apr 07
Are Investors Undervaluing Redcare Pharmacy NV (ETR:RDC) By 26%?

Investors Interested In Redcare Pharmacy NV's (ETR:RDC) Revenues

Mar 25
Investors Interested In Redcare Pharmacy NV's (ETR:RDC) Revenues

Redcare Pharmacy (ETR:RDC) Is Carrying A Fair Bit Of Debt

Feb 13
Redcare Pharmacy (ETR:RDC) Is Carrying A Fair Bit Of Debt

Why Investors Shouldn't Be Surprised By Redcare Pharmacy NV's (ETR:RDC) P/S

Dec 24
Why Investors Shouldn't Be Surprised By Redcare Pharmacy NV's (ETR:RDC) P/S

Is There An Opportunity With Redcare Pharmacy NV's (ETR:RDC) 48% Undervaluation?

Dec 06
Is There An Opportunity With Redcare Pharmacy NV's (ETR:RDC) 48% Undervaluation?

Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?

Sep 07
Is Redcare Pharmacy (ETR:RDC) Using Too Much Debt?

Why Redcare Pharmacy NV (ETR:RDC) Could Be Worth Watching

Aug 02
Why Redcare Pharmacy NV (ETR:RDC) Could Be Worth Watching

Why We're Not Concerned About Redcare Pharmacy NV's (ETR:RDC) Share Price

Jul 17
Why We're Not Concerned About Redcare Pharmacy NV's (ETR:RDC) Share Price

Broker Revenue Forecasts For Shop Apotheke Europe N.V. (ETR:SAE) Are Surging Higher

May 28
Broker Revenue Forecasts For Shop Apotheke Europe N.V. (ETR:SAE) Are Surging Higher

Here's Why Shop Apotheke Europe (ETR:SAE) Can Afford Some Debt

May 11
Here's Why Shop Apotheke Europe (ETR:SAE) Can Afford Some Debt

Revenue & Expenses Breakdown

How Redcare Pharmacy makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XTRA:RDC Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 252,941-386840
30 Sep 252,821-356780
30 Jun 252,676-356580
31 Mar 252,528-486240
31 Dec 242,371-455850
30 Sep 242,227-255320
30 Jun 242,128-95010
31 Mar 241,987-104730
31 Dec 231,799-124440
30 Sep 231,595-164190
30 Jun 231,404-453920
31 Mar 231,272-653930
31 Dec 221,204-783790
30 Sep 221,165-1103680
30 Jun 221,118-1053590
31 Mar 221,081-913200
31 Dec 211,060-742990
30 Sep 211,037-392770
30 Jun 211,038-292560
31 Mar 211,020-182380
31 Dec 20968-172140
30 Sep 20895-151940
30 Jun 20827-201820
31 Mar 20758-271690
31 Dec 19701-361660
30 Sep 19660-411620
30 Jun 19621-401510
31 Mar 19584-401420
31 Dec 18540-341270
30 Sep 18481-311160
30 Jun 18415-281040
31 Mar 18351-24920
31 Dec 17284-21800
30 Sep 17244-22700
30 Jun 17222-20630
31 Mar 17200-20570
31 Dec 16177-18500
30 Sep 16159-13450
30 Jun 16147-13430
31 Mar 16136-12400
31 Dec 15126-11360

Quality Earnings: RDC is currently unprofitable.

Growing Profit Margin: RDC is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: RDC is unprofitable, but has reduced losses over the past 5 years at a rate of 10.3% per year.

Accelerating Growth: Unable to compare RDC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RDC is unprofitable, making it difficult to compare its past year earnings growth to the Consumer Retailing industry (5.8%).

Return on Equity

High ROE: RDC has a negative Return on Equity (-8.22%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/28 05:28
End of Day Share Price 2026/04/28 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Redcare Pharmacy NV is covered by 24 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gerhard SchwarzBaader Helvea Equity Research
Volker BosseBaader Helvea Equity Research
Sarah RobertsBarclays